|
Volumn 20, Issue 6, 2001, Pages 628-630
|
Safety and tolerance of palivizumab administration in a large northern hemisphere trial
a a |
Author keywords
Bronchopulmonary dysplasia; Chronic lung disease; Infectious disease; Monoclonal antibodies; Premature infants; Respiratory disease; Respiratory syncytial virus
|
Indexed keywords
PALIVIZUMAB;
ARTICLE;
BRONCHIOLITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEVER;
HOSPITALIZATION;
HUMAN;
INFANT;
IRRITABILITY;
LUNG DYSPLASIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NERVOUSNESS;
NEWBORN;
PREMATURITY;
PRIORITY JOURNAL;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
RNA VIRUS INFECTION;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFANT, PREMATURE, DISEASES;
INJECTIONS, INTRAMUSCULAR;
MALE;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
TREATMENT OUTCOME;
|
EID: 0034971499
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-200106000-00018 Document Type: Article |
Times cited : (33)
|
References (7)
|